Quick Answer
Health Catalyst, Inc. reported Total Revenue of $311.14 million for fiscal year 2025.
Health Catalyst, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $311.14M +1.5% |
$306.58M +3.6% |
$295.94M +7.1% |
$276.24M +14.2% |
$241.93M +28.1% |
$188.84M +21.9% |
| Revenue (ASC 606) | $311.14M +1.5% |
$306.58M +3.6% |
$295.94M +7.1% |
$276.24M +14.2% |
$241.93M +28.1% |
$188.84M +21.9% |
| Net Income | -$177.97M -156.1% |
-$69.50M +41.2% |
-$118.15M +14.0% |
-$137.40M +10.3% |
-$153.21M -33.2% |
-$115.02M -91.4% |
| Diluted EPS | -$2.55 -121.7% |
-$1.15 +45.0% |
-$2.09 +20.5% |
-$2.63 +18.6% |
-$3.23 -11.0% |
-$2.91 +77.4% |
| Total Assets | $502.64M -41.5% |
$858.93M +22.4% |
$701.81M -6.7% |
$752.29M -9.6% |
$832.10M +44.0% |
$577.74M +91.1% |
| Cash and Equivalents | $50.81M -79.6% |
$249.65M +134.9% |
$106.28M -8.6% |
$116.31M -39.8% |
$193.23M +110.1% |
$91.95M +409.9% |
| Long-Term Debt | $151.62M +0.3% |
$151.18M -33.7% |
$228.03M +0.7% |
$226.52M +25.2% |
$180.94M +7.1% |
$168.99M +250.6% |
| Stockholders Equity | $245.78M -32.7% |
$365.21M -0.5% |
$366.92M -13.7% |
$425.01M -18.6% |
$522.10M +89.1% |
$276.10M +37.6% |
| R&D Expense | $49.77M -14.1% |
$57.95M -20.2% |
$72.63M -4.0% |
$75.68M +20.6% |
$62.73M +17.2% |
$53.52M +15.7% |
| Operating Income | -$160.85M -130.4% |
-$69.81M +45.0% |
-$126.90M +9.4% |
-$140.00M +2.5% |
-$143.65M -49.4% |
-$96.12M -75.2% |
| Shares Outstanding | 72.03M +12.5% |
64.04M +9.9% |
58.30M +5.5% |
55.26M +5.0% |
52.62M +21.3% |
43.38M +18.3% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $76.32M | -0.0% | -5.4% |
| Revenue (ASC 606) | September 30, 2025 | $76.32M | -0.0% | -5.4% |
| Net Income | September 30, 2025 | -$22.23M | -51.0% | +45.8% |
| Diluted EPS | September 30, 2025 | -$0.32 | -33.3% | +45.8% |
| Total Assets | September 30, 2025 | $587.13M | -27.8% | -4.7% |
| Cash and Equivalents | September 30, 2025 | $40.30M | -87.7% | -20.5% |
| Long-Term Debt | September 30, 2025 | $151.51M | +32.2% | +0.1% |
| Stockholders Equity | September 30, 2025 | $331.92M | -6.5% | -4.5% |
| R&D Expense | September 30, 2025 | $12.28M | -13.5% | -0.9% |
| Operating Income | September 30, 2025 | -$17.51M | -27.9% | +52.8% |
| Shares Outstanding | September 30, 2025 | 70.62M | +16.1% | +0.5% |
- Health Catalyst, Inc. reported Total Revenue of $311.14 million for fiscal year 2025.
- Health Catalyst, Inc. showed an increase of +1.5% in Total Revenue compared to the prior fiscal year.
- Health Catalyst, Inc. reported Revenue (ASC 606) of $311.14 million for fiscal year 2025.
- Health Catalyst, Inc. showed an increase of +1.5% in Revenue (ASC 606) compared to the prior fiscal year.
- Health Catalyst, Inc. reported Net Income of -$177.97 million for fiscal year 2025.
- Health Catalyst, Inc. showed a decrease of -156.1% in Net Income compared to the prior fiscal year.
- Health Catalyst, Inc. reported Diluted EPS of $2.55 per share (loss) for fiscal year 2025.
- Health Catalyst, Inc. showed a decrease of -121.7% in Diluted EPS compared to the prior fiscal year.
- Health Catalyst, Inc. reported Total Assets of $502.64 million for fiscal year 2025.
- Health Catalyst, Inc. showed a decrease of -41.5% in Total Assets compared to the prior fiscal year.
- Health Catalyst, Inc. reported Cash and Equivalents of $50.81 million for fiscal year 2025.
- Health Catalyst, Inc. showed a decrease of -79.6% in Cash and Equivalents compared to the prior fiscal year.
- Health Catalyst, Inc. reported Long-Term Debt of $151.62 million for fiscal year 2025.
- Health Catalyst, Inc. showed an increase of +0.3% in Long-Term Debt compared to the prior fiscal year.
- Health Catalyst, Inc. reported Stockholders Equity of $245.78 million for fiscal year 2025.
- Health Catalyst, Inc. showed a decrease of -32.7% in Stockholders Equity compared to the prior fiscal year.
- Health Catalyst, Inc. reported R&D Expense of $49.77 million for fiscal year 2025.
- Health Catalyst, Inc. showed a decrease of -14.1% in R&D Expense compared to the prior fiscal year.
- Health Catalyst, Inc. reported Operating Income of -$160.85 million for fiscal year 2025.
- Health Catalyst, Inc. showed a decrease of -130.4% in Operating Income compared to the prior fiscal year.
- Health Catalyst, Inc. reported Shares Outstanding of 72.03 million shares for fiscal year 2025.
- Health Catalyst, Inc. showed an increase of +12.5% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: